Celebrex in treatment of joint diseases in patients with risk factors of gastropathy and cardiovascular palhalodydevelopment
Literature digest is presented concerning to gastrointestinal and cardiovascular safety of selective COX- 2 inhibitors including results of Russian clinico-endoscopic study of celebrex efficacy and tolerability in osteoarthritis (OA). Celebrex was administered to the pts with risk factors of gastroi...
| Hlavní autoři: | , , |
|---|---|
| Médium: | Článek |
| Jazyk: | Russian |
| Vydáno: |
IMA PRESS LLC
2004-02-01
|
| Edice: | Научно-практическая ревматология |
| Témata: | |
| On-line přístup: | https://rsp.mediar-press.net/rsp/article/view/1234 |